Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Valmira Isufi"'
Autor:
Marianne Luinstra, Wijnand Rutgers, Teus van Laar, Floris Grasmeijer, Anja Begeman, Valmira Isufi, Luc Steenhuis, Paul Hagedoorn, Anne de Boer, Henderik W. Frijlink
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: Inhaled levodopa may quickly resolve off periods in Parkinson’s disease. Our aim was to determine the pharmacokinetics and tolerability of a new levodopa dry-powder inhaler. Methods: A single-centre, single-ascending, single-dose–resp
Externí odkaz:
https://doaj.org/article/ef329ff5c966413691d04238cbec809f
Autor:
Paul Hagedoorn, J Puttenstein, Marianne Luinstra, T van Laar, Valmira Isufi, Henderik W. Frijlink, A.W.F. Rutgers, L de Jong
Publikováno v:
International Journal of Pharmaceutics, 567:118493. Elsevier Bedrijfsinformatie b.v.
Effective inhaler therapy requires correct handling of the inhaler, including being able to prepare the inhaler for use. Motor function impairment and cognitive disabilities, may impose problems on patients with Parkinson's disease when they have to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0315a3f423f68870675ccef5b703b40f
https://research.rug.nl/en/publications/74ca23de-bbac-450a-9b7b-c917f0e8f413
https://research.rug.nl/en/publications/74ca23de-bbac-450a-9b7b-c917f0e8f413
Autor:
Anja Begeman, Paul Hagedoorn, Marianne Luinstra, Luc Steenhuis, Teus van Laar, Floris Grasmeijer, Valmira Isufi, Anne H. de Boer, Wijnand Rutgers, Henderik W. Frijlink
Publikováno v:
Therapeutic advances in chronic disease, 10. SAGE Publications Inc.
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Therapeutic Advances in Chronic Disease
Background: Inhaled levodopa may quickly resolve off periods in Parkinson’s disease. Our aim was to determine the pharmacokinetics and tolerability of a new levodopa dry-powder inhaler. Methods: A single-centre, single-ascending, single-dose–resp